RIO DE JANEIRO, BRAZIL - US researchers are developing a rapid test for Covid-19 that could diagnose an infection within 40 minutes. The new technology is still experimental and is based on the revolutionary CRISPR genetic editing technique.
This system works as a text editor that allows changing the genetic material (DNA) of any living being. The technique was developed in 2011 by Jennifer Doudna and Emmanuelle Charpentier and represented an unprecedented revolution in basic research.
Little by little it also paves the way for the experimental treatment of a number of diseases, including cancer. Now, a team from the . . .